- Home
- SLNH vs CLDI Comparison
SLNH vs CLDI Comparison
Compare SLNH & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLNH
- CLDI
- Stock Information
- Founded
- SLNH 1961
- CLDI 2014
- Country
- SLNH United States
- CLDI United States
- Employees
- SLNH N/A
- CLDI N/A
- Industry
- SLNH EDP Services
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SLNH Technology
- CLDI Health Care
- Exchange
- SLNH Nasdaq
- CLDI Nasdaq
- Market Cap
- SLNH 15.5M
- CLDI 10.2M
- IPO Year
- SLNH N/A
- CLDI N/A
- Fundamental
- Price
- SLNH $0.46
- CLDI $0.59
- Analyst Decision
- SLNH Hold
- CLDI
- Analyst Count
- SLNH 1
- CLDI 0
- Target Price
- SLNH N/A
- CLDI N/A
- AVG Volume (30 Days)
- SLNH 4.5M
- CLDI 51.2M
- Earning Date
- SLNH 08-13-2025
- CLDI 08-12-2025
- Dividend Yield
- SLNH N/A
- CLDI N/A
- EPS Growth
- SLNH N/A
- CLDI N/A
- EPS
- SLNH N/A
- CLDI N/A
- Revenue
- SLNH $31,408,000.00
- CLDI N/A
- Revenue This Year
- SLNH N/A
- CLDI N/A
- Revenue Next Year
- SLNH N/A
- CLDI N/A
- P/E Ratio
- SLNH N/A
- CLDI N/A
- Revenue Growth
- SLNH 2.87
- CLDI N/A
- 52 Week Low
- SLNH $0.36
- CLDI $0.20
- 52 Week High
- SLNH $5.61
- CLDI $3.89
- Technical
- Relative Strength Index (RSI)
- SLNH 39.76
- CLDI 51.60
- Support Level
- SLNH $0.46
- CLDI $0.50
- Resistance Level
- SLNH $0.70
- CLDI $0.91
- Average True Range (ATR)
- SLNH 0.17
- CLDI 0.12
- MACD
- SLNH -0.04
- CLDI -0.01
- Stochastic Oscillator
- SLNH 0.37
- CLDI 23.73
About SLNH Soluna Holdings Inc.
Soluna Holdings Inc is a U.S.-based company that conducts operations through its subsidiary. The group is engaged in the mining of cryptocurrency through data centers that can be powered by renewable energy sources. The data centers buy every excess megawatt to use for batch-oriented, computing-intensive processes such as cryptocurrency mining or machine learning which is a low-risk and low-friction solution to use as a smartphone.
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.